These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17179979)

  • 1. The association between body size, prostate volume and prostate-specific antigen.
    Fowke JH; Motley SS; Cookson MS; Concepcion R; Chang SS; Wills ML; Smith JA
    Prostate Cancer Prostatic Dis; 2007; 10(2):137-42. PubMed ID: 17179979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obesity is negatively associated with prostate-specific antigen in U.S. men, 2001-2004.
    Werny DM; Thompson T; Saraiya M; Freedman D; Kottiri BJ; German RR; Wener M
    Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):70-6. PubMed ID: 17179487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
    Culp S; Porter M
    BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostate volume modifies the association between obesity and prostate cancer or high-grade prostatic intraepithelial neoplasia.
    Fowke JH; Motley SS; Wills M; Cookson MS; Concepcion RS; Eckstein CW; Chang SS; Smith JA
    Cancer Causes Control; 2007 May; 18(4):375-84. PubMed ID: 17334811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
    Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body size and risk of prostate cancer in Jamaican men.
    Jackson MD; Walker SP; Simpson CM; McFarlane-Anderson N; Bennett FI; Coard KC; Aiken WD; Tulloch T; Paul TJ; Wan RL
    Cancer Causes Control; 2010 Jun; 21(6):909-17. PubMed ID: 20157773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
    Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
    Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
    Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
    BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
    Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship of prostate-specific antigen and prostate volume in Korean men with biopsy-proven benign prostatic hyperplasia.
    Lee SE; Chung JS; Han BK; Moon KH; Hwang SI; Lee HJ; Choe G; Hong SK
    Urology; 2008 Mar; 71(3):395-8. PubMed ID: 18342171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Which obesity index best correlates with prostate volume, prostate-specific antigen, and lower urinary tract symptoms?
    Yang HJ; Doo SW; Yang WJ; Song YS
    Urology; 2012 Jul; 80(1):187-90. PubMed ID: 22626573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
    Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
    Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum prostate-specific antigen as a predictor of prostate volume in Korean men with lower urinary tract symptoms.
    Shim HB; Lee JK; Jung TY; Ku JH
    Prostate Cancer Prostatic Dis; 2007; 10(2):143-8. PubMed ID: 17199133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
    Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
    J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
    Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
    BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Body mass index influences prostate-specific antigen in men younger than 60 years of age.
    Kim YJ; Han BK; Hong SK; Byun SS; Kim WJ; Lee SE
    Int J Urol; 2007 Nov; 14(11):1009-12. PubMed ID: 17956528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate specific antigen mass ratio potential as a prostate cancer screening tool.
    Choi HC; Park JH; Cho BL; Son KY; Kwon HT
    J Urol; 2010 Aug; 184(2):488-93. PubMed ID: 20620404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical impact of body mass index on prostate biopsy in patients with intermediate PSA levels].
    Sekita N; Suzuki H; Kamijima S; Chini K; Fujimura M; Mikami K
    Hinyokika Kiyo; 2008 Jul; 54(7):479-83. PubMed ID: 18697492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
    Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
    Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
    Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
    BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.